In the last week, the Biotech industry is up 1.8%, with Lin BioScience up 17%. In contrast, the industry has lost 7.2% in the last 12 months. Looking forward, earnings are forecast to grow by 53% annually.
Has the Taiwanese Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Fri, 23 May 2025 | NT$490.2b | NT$30.0b | -NT$6,443,317,000.00 | 31.3x | -76.1x | 16.3x |
Sun, 20 Apr 2025 | NT$470.0b | NT$28.3b | -NT$7,180,905,000.00 | 31x | -65.4x | 16.6x |
Tue, 18 Mar 2025 | NT$531.4b | NT$28.1b | -NT$8,214,097,000.00 | 32.9x | -64.7x | 18.9x |
Thu, 13 Feb 2025 | NT$598.1b | NT$24.8b | -NT$10,902,841,000.00 | 38.1x | -54.9x | 24.1x |
Sat, 11 Jan 2025 | NT$562.3b | NT$24.8b | -NT$10,902,841,000.00 | 34.9x | -51.6x | 22.7x |
Mon, 09 Dec 2024 | NT$514.8b | NT$24.8b | -NT$10,848,531,000.00 | 37.2x | -47.5x | 20.8x |
Wed, 06 Nov 2024 | NT$548.6b | NT$23.5b | -NT$10,829,095,000.00 | 42.5x | -50.7x | 23.4x |
Fri, 04 Oct 2024 | NT$551.8b | NT$23.5b | -NT$10,829,095,000.00 | 36x | -51x | 23.5x |
Sun, 01 Sep 2024 | NT$583.8b | NT$23.5b | -NT$10,883,302,000.00 | 35.1x | -53.6x | 24.9x |
Tue, 30 Jul 2024 | NT$549.0b | NT$21.9b | -NT$11,053,865,000.00 | 42.1x | -49.7x | 25x |
Thu, 27 Jun 2024 | NT$520.7b | NT$21.9b | -NT$11,110,643,000.00 | 43.2x | -46.9x | 23.7x |
Sat, 25 May 2024 | NT$489.1b | NT$21.9b | -NT$11,084,581,000.00 | 42x | -44.1x | 22.3x |
Mon, 22 Apr 2024 | NT$429.2b | NT$21.1b | -NT$12,242,614,000.00 | 46.6x | -35.1x | 20.3x |
Wed, 20 Mar 2024 | NT$433.4b | NT$21.0b | -NT$10,159,738,000.00 | 44.5x | -42.7x | 20.6x |
Fri, 16 Feb 2024 | NT$438.6b | NT$19.9b | -NT$9,857,794,000.00 | 40.4x | -44.5x | 22x |
Sun, 14 Jan 2024 | NT$458.8b | NT$19.8b | -NT$9,748,146,000.00 | 38.9x | -47.1x | 23.2x |
Tue, 12 Dec 2023 | NT$472.7b | NT$19.9b | -NT$9,737,975,000.00 | 43x | -48.5x | 23.8x |
Thu, 09 Nov 2023 | NT$486.4b | NT$18.5b | -NT$10,820,022,000.00 | 50.3x | -45x | 26.2x |
Sat, 07 Oct 2023 | NT$472.2b | NT$18.3b | -NT$10,774,226,000.00 | 45.1x | -43.8x | 25.8x |
Mon, 04 Sep 2023 | NT$493.2b | NT$18.3b | -NT$10,596,353,000.00 | 43.3x | -46.5x | 26.9x |
Wed, 02 Aug 2023 | NT$475.6b | NT$18.6b | -NT$10,793,316,000.00 | 51.4x | -44.1x | 25.6x |
Fri, 30 Jun 2023 | NT$493.3b | NT$18.7b | -NT$10,709,428,000.00 | 44.4x | -46.1x | 26.4x |
Sun, 28 May 2023 | NT$490.6b | NT$19.0b | -NT$9,947,560,000.00 | 44.2x | -49.3x | 25.9x |
Tue, 25 Apr 2023 | NT$516.4b | NT$18.4b | -NT$9,803,110,000.00 | 40.8x | -52.7x | 28x |
Thu, 23 Mar 2023 | NT$494.6b | NT$22.5b | -NT$7,261,002,000.00 | 37.1x | -68.1x | 22x |
Sat, 18 Feb 2023 | NT$521.9b | NT$21.8b | -NT$7,832,470,000.00 | 38x | -66.6x | 23.9x |
Mon, 16 Jan 2023 | NT$487.4b | NT$21.8b | -NT$7,778,690,000.00 | 35.9x | -62.7x | 22.4x |
Wed, 14 Dec 2022 | NT$518.7b | NT$21.8b | -NT$7,522,211,000.00 | 37.6x | -69x | 23.8x |
Fri, 11 Nov 2022 | NT$479.5b | NT$23.1b | -NT$6,619,282,000.00 | 36.2x | -72.4x | 20.8x |
Sun, 09 Oct 2022 | NT$511.1b | NT$23.1b | -NT$6,633,590,000.00 | 38.2x | -77.1x | 22.1x |
Tue, 06 Sep 2022 | NT$655.8b | NT$23.0b | -NT$6,502,954,000.00 | 45.3x | -100.8x | 28.5x |
Thu, 04 Aug 2022 | NT$537.7b | NT$22.5b | -NT$5,642,821,000.00 | 31.8x | -95.3x | 23.9x |
Sat, 02 Jul 2022 | NT$530.6b | NT$22.5b | -NT$5,642,821,000.00 | 30.6x | -94x | 23.5x |
Mon, 30 May 2022 | NT$498.2b | NT$22.5b | -NT$5,642,821,000.00 | 31.8x | -88.3x | 22.1x |
-88.3x
How does Taiwanese Biotech compare with similar industries?
TW Market | -0.24% | |
Healthcare | 1.89% | |
Biotech | -1.00% | |
Biotech | -1.00% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
4726 Mycenax Biotech | NT$37.90 | 13.6% +NT$941.9m | -10.4% | PS10.8x | |
6617 Gongwin Biopharm Holdings | NT$114.00 | 6.5% +NT$882.4m | -39.4% | PS419.9x | |
6541 Tanvex BioPharma | NT$55.70 | 4.1% +NT$524.7m | 46.2% | PS163.6x | |
6810 Bio Preventive Medicine | NT$31.90 | 38.7% +NT$440.1m | -16.3% | n/a | |
6712 Ever Supreme Bio Technology | NT$170.50 | 3.6% +NT$430.3m | -4.8% | PE31.3x |